Pharmaceutical Analysis

Regulatory Affairs has a very specific meaning within the healthcare industries. Its regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving new regulations and adapting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation. The global regulatory affairs outsourcing market had a valuation of US$1.9 bn in 2014. The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.

  • Novel approaches to analytical and bioanalytical methods
  • Bioanalytical techniques
  • Chromatography and techniques
  • Spectroscopic techniques
  • Nuclear magnetic resonanace
  • Mass spectroscopy
  • Regulatory issues and biosafety challenges in bioanalysis
  • Applications of analytical and bioanalytical methods

Related Conference of Pharmaceutical Analysis

October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
February 28-March 01, 2019

Global Pharmaceutical & Pharma Industry Conference

Osaka, Japan
March 18-19, 2019

13th International Conference on Biosimilars and Biologics

Amsterdam | Netherlands
August 5-6, 2019

13th Asian Biologics and Biosimilars Congress

Melbourne, Australia

Pharmaceutical Analysis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in